PDPK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.659000E-01
Normal-vs-Stage2
2.506000E-01
Normal-vs-Stage3
9.106400E-02
Normal-vs-Stage4
8.149800E-01
Stage1-vs-Stage2
2.771400E-01
Stage1-vs-Stage3
1.815970E-02
Stage1-vs-Stage4
9.585400E-01
Stage2-vs-Stage3
5.704400E-02
Stage2-vs-Stage4
4.176000E-01
Stage3-vs-Stage4
1.126170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.747000E-01
Normal-vs-AfricanAmerican
6.440200E-01
Normal-vs-Asian
1.531430E-01
Caucasian-vs-AfricanAmerican
5.140400E-01
Caucasian-vs-Asian
2.375600E-01
AfricanAmerican-vs-Asian
1.974850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.198400E-01
Normal-vs-Female
2.363200E-01
Male-vs-Female
7.372800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.397600E-01
Normal-vs-Age(41-60Yrs)
3.755600E-01
Normal-vs-Age(61-80Yrs)
2.824400E-01
Normal-vs-Age(81-100Yrs)
1.002180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.544600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.781000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.820600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.534000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.617800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.590000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.283410E-01
Normal-vs-Daily Drinker
1.645580E-01
Normal-vs-Weekly Drinker
1.810620E-01
Normal-vs-Occasional Drinker
5.656600E-01
Normal-vs-Social Drinker
6.697000E-01
Non Drinker-vs-Daily Drinker
6.437600E-01
Non Drinker-vs-Weekly Drinker
6.516400E-01
Non Drinker-vs-Occasional Drinker
1.878230E-01
Non Drinker-vs-Social Drinker
8.873900E-02
Daily Drinker-vs-Weekly Drinker
9.768600E-01
Daily Drinker-vs-Occasional Drinker
1.527960E-01
Daily Drinker-vs-Social Drinker
8.394300E-02
Weekly Drinker-vs-Occasional Drinker
1.973570E-01
Weekly Drinker-vs-Social Drinker
1.141610E-01
Occasional Drinker-vs-Social Drinker
7.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.987600E-02
Normal-vs-Grade 2
9.855600E-03
Normal-vs-Grade 3
1.283720E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.282200E-01
Grade 1-vs-Grade 3
5.718400E-01
Grade 1-vs-Grade 4
6.987600E-02
Grade 2-vs-Grade 3
5.921200E-01
Grade 2-vs-Grade 4
9.855600E-03
Grade 3-vs-Grade 4
1.283720E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.473700E-02
Normal-vs-NonDiabetic
2.711400E-01
Diabetic-vs-NonDiabetic
1.847420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.842400E-01
Normal-vs-NoPancreatitis
2.421800E-01
Pancreatitis-vs-NoPancreatitis
8.670400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.786800E-01
Normal-vs-N1
2.508400E-01
N0-vs-N1
7.523800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.138400E-01
Normal-vs-TP53-NonMutant
7.048800E-01
TP53-Mutant-vs-TP53-NonMutant
4.876000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
